MXIM 10-Q Quarterly Report March 30, 2019

MAXIM INTEGRATED PRODUCTS INC

10-Qs and 10-Ks

10-K	Fiscal year ended June 26, 2021
10-Q	Quarter ended March 27, 2021
10-Q	Quarter ended Dec. 26, 2020
10-Q	Quarter ended Sept. 26, 2020
10-K	Fiscal year ended June 27, 2020
10-Q	Quarter ended March 28, 2020
10-Q	Quarter ended Dec. 28, 2019
10-Q	Quarter ended Sept. 28, 2019
10-K	Fiscal year ended June 29, 2019
10-Q	Quarter ended March 30, 2019
10-Q	Quarter ended Dec. 29, 2018
10-Q	Quarter ended Sept. 29, 2018
10-K	Fiscal year ended June 30, 2018
10-Q	Quarter ended March 31, 2018
10-Q	Quarter ended Dec. 30, 2017
10-Q	Quarter ended Sept. 23, 2017
10-K	Fiscal year ended June 24, 2017
10-Q	Quarter ended March 25, 2017
10-Q	Quarter ended Dec. 24, 2016
10-Q	Quarter ended Sept. 24, 2016
10-K	Fiscal year ended June 25, 2016
10-Q	Quarter ended March 26, 2016
10-Q	Quarter ended Dec. 26, 2015
10-Q	Quarter ended Sept. 26, 2015
10-K	Fiscal year ended June 27, 2015
10-Q	Quarter ended March 28, 2015
10-Q	Quarter ended Dec. 27, 2014
10-Q	Quarter ended Sept. 27, 2014
10-K	Fiscal year ended June 28, 2014
10-Q	Quarter ended March 29, 2014
10-Q	Quarter ended Dec. 28, 2013
10-Q	Quarter ended Sept. 28, 2013
10-K	Fiscal year ended June 29, 2013
10-Q	Quarter ended March 30, 2013
10-Q	Quarter ended Dec. 29, 2012
10-Q	Quarter ended Sept. 29, 2012
10-K	Fiscal year ended June 30, 2012
10-Q	Quarter ended March 31, 2012
10-Q	Quarter ended Dec. 31, 2011
10-Q	Quarter ended Sept. 24, 2011
10-K	Fiscal year ended June 25, 2011
10-Q	Quarter ended March 26, 2011
10-Q	Quarter ended Dec. 25, 2010
10-Q	Quarter ended Sept. 25, 2010
10-K	Fiscal year ended June 26, 2010
10-Q	Quarter ended March 27, 2010
10-Q	Quarter ended Dec. 26, 2009

PROXIES

DEF 14A	Filed on Sept. 28, 2020
DEF 14A	Filed on Sept. 27, 2019
DEF 14A	Filed on Sept. 28, 2018
DEF 14A	Filed on Sept. 29, 2017
DEF 14A	Filed on Sept. 30, 2016
DEF 14A	Filed on Sept. 30, 2015
DEF 14A	Filed on Oct. 1, 2014
DEF 14A	Filed on Oct. 1, 2013
DEF 14A	Filed on Oct. 1, 2012
DEF 14A	Filed on Sept. 30, 2011
DEF 14A	Filed on Sept. 29, 2010

10-Q 1 maximq31910-q.htm 10-Q Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q



[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended March 30, 2019



[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from ________ to ________.

Commission file number 1-34192

MAXIM INTEGRATED PRODUCTS, INC.

(Exact name of registrant as specified in its charter)



Delaware (State or Other Jurisdiction of Incorporation or Organization)		94-2896096 (I.R.S. Employer I. D. No.)

160 Rio Robles

San Jose, California 95134

(Address of Principal Executive Offices including Zip Code)

(408) 601-1000

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES [x] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [x] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller” reporting company in Rule 12b-2 of the Exchange Act. (Check one):



Large accelerated filer [x]	Accelerated filer [ ]	Non-accelerated filer [ ] (Do not check if a smaller reporting company)	Smaller reporting company [ ]	Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisited financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). (Check one): YES [ ] NO [x]

As of April 18, 2019 there were 272,425,069 shares of Common Stock, par value $.001 per share, of the registrant outstanding.

MAXIM INTEGRATED PRODUCTS, INC.

INDEX



PART I - FINANCIAL INFORMATION		Page

Item 1. Financial Statements (Unaudited)		3

Condensed Consolidated Balance Sheets as of March 30, 2019 and June 30, 2018		3

Condensed Consolidated Statements of Income for the Three and Nine Months Ended March 30, 2019 and March 31, 2018		4

Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended March 30, 2019 and March 31, 2018		5

Condensed Consolidated Statements of Shareholders' Equity for the Three and Nine Months Ended March 30, 2019 and March 31, 2018		6

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 30, 2019 and March 31, 2018		8

Notes to Condensed Consolidated Financial Statements		9

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		27

Item 3. Quantitative and Qualitative Disclosures About Market Risk		32

Item 4. Controls and Procedures		32

PART II - OTHER INFORMATION		33

Item 1. Legal Proceedings		33

Item 1A. Risk Factors		33

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		33

Item 3. Defaults Upon Senior Securities		33

Item 4. Mine Safety Disclosures		33

Item 5. Other Information		33

Item 6. Exhibits		34

SIGNATURE		35

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)



	March 30, 2019			June 30, 2018
	(in thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	1,654,563		$	1,543,484
Short-term investments	243,864			1,082,915
Total cash, cash equivalents and short-term investments	1,898,427			2,626,399
Accounts receivable, net of allowances of $608 at March 30, 2019 and $140,296 at June 30, 2018	381,152			280,072
Inventories	272,832			282,390
Other current assets	24,358			21,548
Total current assets	2,576,769			3,210,409
Property, plant and equipment, net	571,955			579,364
Intangible assets, net	61,036			78,246
Goodwill	532,251			532,251
Other assets	61,843			51,291
TOTAL ASSETS	$	3,803,854		$	4,451,561

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	86,798		$	92,572
Price adjustment and other revenue reserves	106,011			—
Income taxes payable	44,179			17,961
Accrued salary and related expenses	128,365			151,682
Accrued expenses	33,644			35,774
Current portion of debt	—			499,406
Total current liabilities	398,997			797,395
Long-term debt	992,225			991,147
Income taxes payable	688,780			661,336
Other liabilities	61,105			70,743
Total liabilities	2,141,107			2,520,621

Commitments and contingencies (Note 11)

Stockholders’ equity:
Common stock and capital in excess of par value	279			279
Retained earnings	1,672,938			1,945,646
Accumulated other comprehensive loss	(10,470		)	(14,985		)
Total stockholders’ equity	1,662,747			1,930,940
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY	$	3,803,854		$	4,451,561

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)



	Three Months Ended					Nine Months Ended
	March 30, 2019		March 31, 2018			March 30, 2019		March 31, 2018
	(in thousands, except per share data)

Net revenues	$	542,383	$	648,599		$	1,757,784	$	1,846,913
Cost of goods sold	201,552		224,653			613,669		639,460
Gross margin	340,831		423,946			1,144,115		1,207,453
Operating expenses:
Research and development	107,075		114,390			330,086		338,886
Selling, general and administrative	74,116		81,304			233,487		240,308
Intangible asset amortization	756		876			2,285		3,623
Impairment of long-lived assets	—		—			753		892
Severance and restructuring expenses	1,744		2,272			3,917		14,227
Other operating expenses (income), net	—		266			60		(1,535		)
Total operating expenses	183,691		199,108			570,588		596,401
Operating income	157,140		224,838			573,527		611,052
Interest and other income (expense), net	3,318		(2,534		)	3,244		(9,868		)
Income before provision for income taxes	160,458		222,304			576,771		601,184
Income tax provision (benefit)	29,845		28,677			116,843		328,038
Net income	$	130,613	$	193,627		$	459,928	$	273,146

Earnings per share:
Basic	$	0.48	$	0.69		$	1.67	$	0.97
Diluted	$	0.47	$	0.68		$	1.64	$	0.95

Shares used in the calculation of earnings per share:
Basic	273,221		280,850			275,831		281,525
Diluted	276,610		285,881			279,680		286,221

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)



	Three Months Ended						Nine Months Ended
	March 30, 2019			March 31, 2018			March 30, 2019		March 31, 2018
	(in thousands)
Net income	$	130,613		$	193,627		$	459,928	$	273,146
Other comprehensive income (loss), net of tax:
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $97, $274, ($131), and $274, respectively	1,139			(1,213		)	3,116		(3,433		)
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $69, $6, $(241), and $(45), respectively	(351		)	(217		)	1,167		133
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(23), $(4), $(60), and $(168), respectively	78			18			232		(14		)
Other comprehensive income (loss), net	866			(1,412		)	4,515		(3,314		)
Total comprehensive income	$	131,479		$	192,215		$	464,443	$	269,832

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Unaudited)



	Three Months Ended March 30, 2019
	Common Stock				Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	Shares		Par Value		Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	(in thousands)

Balance, December 29, 2018	274,326		$	279	$	—		$	1,766,471		$	(11,336	)	$	1,755,414
Net income	—		—		—			130,613			—			130,613
Other comprehensive income, net	—		—		—			—			866			866
Repurchase of common stock	(2,210	)	—		(18,411		)	(98,580		)	—			(116,991		)
Net issuance of restricted stock units	402		—		(9,582		)	—			—			(9,582		)
Stock options exercised	177		—		5,143			—			—			5,143
Stock-based compensation	—		—		22,850			—			—			22,850
Common stock issued under Employee Stock Purchase Plan	—		—		—			—			—			—
Dividends paid, $0.46 per common share	—		—		—			(125,566		)	—			(125,566		)
Balance, March 30, 2019	272,695		$	279	$	—		$	1,672,938		$	(10,470	)	$	1,662,747

	Nine Months Ended March 30, 2019
	Common Stock				Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	Shares		Par Value		Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	(in thousands)
Balance, June 30, 2018	278,664		$	279	$	—		$	1,945,646		$	(14,985	)	$	1,930,940
Net income	—		—		—			459,928			—			459,928
Other comprehensive income, net	—		—		—			—			4,515			4,515
Repurchase of common stock	(8,032	)	—		(82,155		)	(354,892		)	—			(437,047		)
Cumulative effect adjustment for adoption of ASU 2016-01	—		—		—			2,487			—			2,487
Net issuance of restricted stock units	980		—		(23,026		)	—			—			(23,026		)
Stock options exercised	699		—		18,986			—			—			18,986
Stock-based compensation	—		—		65,035			—			—			65,035
Modification of liability to equity instruments ⁽¹⁾	—		—		3,471			—			—			3,471
Common stock issued under Employee Stock Purchase Plan	384		—		17,689			—			—			17,689
Dividends paid, $1.38 per common share	—		—		—			(380,231		)	—			(380,231		)
Balance, March 30, 2019	272,695		$	279	$	—		$	1,672,938		$	(10,470	)	$	1,662,747

_____________________________

(1) In December 2018, $3.5 million was reclassified from accrued salaries to additional paid-in capital due to a settlement agreement relating to the expiration of stock options.

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Unaudited)



	Three Months Ended March 31, 2018
	Common Stock					Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	Shares		Par Value			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	(in thousands)

Balance, December 30, 2017	281,438		$	283		$	—		$	1,997,207		$	(11,792	)	$	1,985,698
Net income	—		—			—			193,627			—			193,627
Other comprehensive income, net	—		—			—			—			(1,412		)	(1,412		)
Repurchase of common stock	(2,140	)	(2		)	(18,659		)	(109,039		)	—			(127,700		)
Net issuance of restricted stock units	387		1			(9,642		)	—			—			(9,641		)
Stock options exercised	294		1			7,714			—			—			7,715
Stock-based compensation	—		—			20,587			—			—			20,587
Common stock issued under Employee Stock Purchase Plan	—		—			—			—			—			—
Dividends paid, $0.42 per common share	—		—			—			(117,883		)	—			(117,883		)
Balance, March 31, 2018	279,979		$	283		$	—		$	1,963,912		$	(13,204	)	$	1,950,991

	Nine Months Ended March 31, 2018
	Common Stock					Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	Shares		Par Value			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	(in thousands)
Balance, June 24, 2017	282,912		$	283		$	—		$	2,212,301		$	(9,890	)	$	2,202,694
Net income	—		—			—			273,146			—			273,146
Other comprehensive (loss), net	—		—			—			—			(3,314		)	(3,314		)
Repurchase of common stock	(5,286	)	(3		)	(79,174		)	(200,769		)	—			(279,946		)
Net issuance of restricted stock units	906		1			(21,162		)	—			—			(21,161		)
Stock options exercised	1,031		2			26,382			—			—			26,384
Stock-based compensation	—		—			58,979			—			—			58,979
Common stock issued under Employee Stock Purchase Plan	416		—			14,975			—			—			14,975
Dividends paid, $1.14 per common share	—		—			—			(320,766		)	—			(320,766		)
Balance, March 31, 2018	279,979		$	283		$	—		$	1,963,912		$	(13,204	)	$	1,950,991

See accompanying Notes to Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)



	Nine Months Ended
	March 30, 2019			March 31, 2018
	(in thousands)
Cash flows from operating activities:
Net income	$	459,928		$	273,146
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	64,973			58,932
Depreciation and amortization	85,176			109,768
Deferred taxes	(12,161		)	6,257
Loss (gain) on disposal of property, plant and equipment	3,324			572
Impairment of investments in privately-held companies	265			850
Other adjustments	—			42
Changes in assets and liabilities:
Accounts receivable	5,475			(60,194		)
Inventories	9,620			(23,326		)
Other current assets	(3,026		)	31,703
Accounts payable	(10,971		)	3,429
Income taxes payable	53,662			280,664
Deferred margin on shipments to distributors	—			(14,974		)
Accrued salary and related expenses	(19,845		)	1,826
All other accrued liabilities	1,953			4,110
Net cash provided by (used in) operating activities	638,373			672,805
Cash flows from investing activities:
Purchases of property, plant and equipment	(52,170		)	(53,664		)
Proceeds from sale of property, plant and equipment	34			5,761
Proceeds from sale of available-for-sale securities	30,192			100,004
Proceeds from maturity of available-for-sale securities	1,027,083			422,500
Payment in connection with business acquisition, net of cash acquired	(2,949		)	(57,773		)
Purchases of available-for-sale securities	(214,587		)	(1,122,291		)
Purchases of privately-held companies' securities	(1,676		)	(3,356		)
Other investing activities	(540		)	—
Net cash provided by (used in) investing activities	785,387			(708,819		)
Cash flows from financing activities:
Repayment of debt	(500,000		)	—
Contingent consideration paid	(9,052		)	—
Net issuance of restricted stock units	(23,026		)	(21,162		)
Proceeds from stock options exercised	18,986			26,383
Issuance of common stock under employee stock purchase program	17,689			14,975
Repurchase of common stock	(437,047		)	(279,944		)
Dividends paid	(380,231		)	(320,766		)
Net cash provided by (used in) financing activities	(1,312,681		)	(580,514		)
Net increase (decrease) in cash and cash equivalents	111,079			(616,528		)
Cash and cash equivalents:
Beginning of period	$	1,543,484		$	2,246,121
End of period	$	1,654,563		$	1,629,593
Supplemental disclosures of cash flow information:
Cash paid, net, during the period for income taxes	$	74,385		$	17,281
Cash paid for interest	$	31,751		$	31,750
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	$	15,252		$	6,798

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1: BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair statement have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the nine months ended March 30, 2019 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2018 .

The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal year 2018 was a 53-week fiscal year and fiscal year 2019 is a 52-week fiscal year. The second quarter of fiscal year 2018 was a 14-week quarter and the second quarter of fiscal year 2019 was a 13-week quarter.

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Recently Issued Accounting Pronouncements

(i) New Accounting Updates Recently Adopted

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606) . This standard provides a single set of guidelines for revenue recognition to be used across all industries. Under the new standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires reporting companies to disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.

On July 1, 2018, the Company adopted Topic 606 and related amendments (ASU 2015-14, Deferral of the Effective Date ; ASU 2016-08, Principal versus Agent Considerations ; ASU 2016-10, Identifying Performance Obligations and Licensing , ASU 2016-12, Narrow-Scope Improvements and Practical Expedients and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers ) using the modified retrospective method applied to all contracts that are not completed at the date of initial application (i.e., July 1, 2018). Results for reporting periods beginning after July 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with historic accounting standards under Topic 605.

There was no impact on the opening retained earnings as of July 1, 2018 due to the adoption of Topic 606. However, in conjunction with the adoption of the new standard, the Company recorded a reclassification of accrued revenue reserves for price adjustments and other revenue reserves from accounts receivable, net to price adjustment and other revenue reserves within current liabilities.

The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands):



	As of June 30, 2018		Effect of Adoption of Topic 606		As of July 1, 2018

Accounts receivable, net	$	280,072	$	141,652	$	421,724
Price adjustment and other revenue reserves	—		141,652		141,652

Balance Sheet Reclassification

Under Topic 605, the gross amount of accrued revenue reserves for price adjustments and other revenue reserves of $141.7 million was included within accounts receivable, net as of June 30, 2018. Subsequent to the adoption of Topic 606, such balances are presented on a gross basis as accrued price adjustments and other revenue reserves of $141.7 million , which is presented in the price adjustment and other revenue reserves balance sheet caption.

The adoption of Topic 606 has no impact on the total cash flows from operating, investing, or financing activities on the Condensed Consolidated Statements of Cash Flows.

The following table summarizes the impacts of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheet as of March 30, 2019 (in thousands):



	As Reported		If Reported Under Topic 605		Effect of Adoption of Topic 606

Accounts receivable, net	$	381,152	$	275,141	$	106,011
Price adjustment and other revenue reserves	106,011		—		106,011

Practical Expedients and Elections


•	The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for services performed.


•	The Company has elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.


•	The Company has elected to exclude sales, use, value added, and some excise taxes, if applicable, from the measurement of the transaction price.

Updated Revenue Recognition Policy

The Company recognizes revenue for sales to direct customers and distribution customers ("distributors") when a customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. The transaction price is calculated as selling price net of variable considerations, such as distributor price adjustments. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it is expected to be entitled. The transaction price does not include amounts collected on behalf of another party, such as sales taxes or value added tax. The Company elected the practical expedient to not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company estimates returns for sales to direct customers and distributors based on historical return rates applied against current period gross revenue. Specific customer returns and allowances are considered within this estimate.

Accounts receivable from direct customers and distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment, at which point the Company has a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title to such inventory from its consigned location, at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of the agreement with the related customers. Customers are generally required to pay for products and services within the Company’s standard terms, which is net 30 days from the date of invoice. The Company does not have any significant financing components greater than one year.

The Company estimates potential future returns and sales allowances related to current period product revenue. Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances. Estimates made may differ from actual returns and sales allowances. These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material.

Distributor price adjustments are estimated based on the Company's historical experience rates and also considering economic conditions and contractual terms. To date, actual distributor claims activity has been materially consistent with the estimates that the Company has made based on its historical rates.

The Company's revenue arrangements do not contain significant financing components. Revenue is recognized over a period of time when it is assessed that performance obligations are satisfied over a period rather than at a point in time. When any of the following criteria is fulfilled, revenue is recognized over a period of time:

(a) The customer simultaneously receives and consumes the benefits provided by the performance completed.

(b) Performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced.

(c) Performance does not create an asset with an alternative use, and has an enforceable right to payment for performance completed to date.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, with further classifications made recently with the issuance of ASU 2018-03 and ASU 2018-04, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. The application of this ASU was made by the means of a cumulative-effect adjustment to the balance sheet for the equity securities that qualify for the practical expedient to estimate fair value using the net asset value per share. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) is being applied prospectively to equity investments that exist as of the date of adoption. The Company adopted ASU 2016-01 in the first quarter of fiscal year 2019. As a result of this adoption, the Company recognized an increase of $2.5 million , net of tax, in retained earnings at the beginning of fiscal year 2019.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory . ASU 2016-16 requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs instead of when the asset is sold. The Company adopted ASU 2016-16 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which requires employers that offer or maintain defined benefit plans to disaggregate the service component from the other components of net benefit cost and provides guidance on presentation of the service component and the other components of net benefit cost in the statement of operations. The application of ASU 2017-07 requires retrospective basis for all periods presented. The Company adopted ASU 2017-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this standard provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. Unless the changes in terms or conditions meet all three criteria outlined in the guidance, modification accounting should be applied. The three criteria relate to changes in the terms and conditions that affect the fair value, vesting conditions, or classification of a share-based payment award. The guidance is required to be applied prospectively to an award modified on or after the adoption date. The Company adopted ASU 2017-09 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . This standard provides guidance about the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. The Company adopted ASU 2018-02 in the first quarter of fiscal year 2019. There was no material change to the Company's consolidated financial statements as a result of this adoption.

In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting . This ASU largely aligns the accounting for share-based payment awards to employees and non-employees. Under the new guidance, both sets of awards, for employees and non-employees, will essentially follow the same model, with small discrepancies related to the term assumption when valuing non-employee awards. The Company adopted ASU 2018-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

SEC Disclosure Update and Simplification. In August 2018, the SEC adopted a final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant and outdated. The rule also requires registrants to include in their interim financial statements a reconciliation of changes in stockholders' equity in the notes or as a separate statement. The final rule was effective on November 5, 2018. The Company has adopted the final rule as of December 29, 2018, and has included a reconciliation of the changes in stockholders' equity in this Form 10-Q.

(ii) Recent Accounting Updates Not Yet Effective

In February 2016, the FASB issued ASU 2016-02, Leases and subsequent amendments to the initial update: ASU 2017-13, ASU 2018-01, ASU 2018-11, ASU 2018-20 and ASU 2019-01 (collectively, Topic 842 ), which supersede the lease accounting requirements in Topic 840. Topic 842 requires a dual approach for lessee accounting under which a lessee would account for leases as finance leases or operating leases. Both finance leases and operating leases will result in the lessee recognizing a right-of-use asset and a corresponding lease liability. For finance leases, the lessee would recognize interest expense and amortization of the right-of-use asset, and for operating leases, the lessee would recognize a straight-line total lease expense. The guidance also requires qualitative and specific quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand more about the nature of an entity’s leasing activities, including significant judgments and changes in judgments. This guidance is effective beginning in the first quarter of fiscal year 2020 on a modified retrospective approach. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and expects that there will be a material increase in assets and liabilities on the Consolidated Balance Sheets at adoption due to the recognition of right-of-use assets and related lease liabilities. Upon adoption, the Company expects that its financial statement disclosures will be expanded to present additional details of its leasing arrangements.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which improves disclosures by removing, modifying and adding disclosure requirements related to fair value measurements. The update highlights adjustments in disclosures for changes in the fair value of Level 1, Level 2, and Level 3 instruments. This guidance is effective beginning in the first quarter of fiscal year 2021, with early adoption permitted. The Company does not believe that this update will have a material impact on its consolidated financial statements.

NOTE 3: BALANCE SHEET COMPONENTS

Inventories consist of:



	March 30, 2019		June 30, 2018
Inventories:	(in thousands)
Raw materials	$	18,799	$	16,251
Work-in-process	172,020		173,859
Finished goods	82,013		92,280
	$	272,832	$	282,390

Property, plant and equipment, net consists of:



	March 30, 2019			June 30, 2018
Property, plant and equipment, net:	(in thousands)
Land	$	17,731		$	17,731
Buildings and building improvements	258,642			254,733
Machinery, equipment and software	1,358,892			1,309,487
	1,635,265			1,581,951
Less: accumulated depreciation	(1,063,310		)	(1,002,587		)
	$	571,955		$	579,364

Accrued salary and related expenses consist of:



	March 30, 2019		June 30, 2018
Accrued salary and related expenses:	(in thousands)
Accrued vacation	$	28,831	$	30,695
Accrued bonus	56,187		92,288
Accrued salaries	13,711		8,210
ESPP withholding	15,634		5,158
Accrued fringe benefits	8,075		4,752
Other	5,927		10,579
	$	128,365	$	151,682

NOTE 4: FAIR VALUE MEASUREMENTS

The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows:

Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.

The Company’s Level 1 assets consist of money market funds.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

The Company’s Level 2 assets and liabilities consist of U.S. Treasury securities, agency securities, corporate debt securities, certificates of deposit, commercial paper and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company's Level 3 assets and liabilities consist of acquisition related contingent consideration liabilities.

Assets and liabilities measured at fair value on a recurring basis were as follows:



	As of March 30, 2019								As of June 30, 2018
	Fair Value Measurements Using						Total Balance		Fair Value Measurements Using						Total Balance
	Level 1		Level 2		Level 3		Total Balance		Level 1		Level 2		Level 3		Total Balance
	(in thousands)
Assets
Cash and cash equivalents
Agency securities	$	—	$	—	$	—	$	—	$	—	$	13,946	$	—	$	13,946
Certificates of deposit	—		—		—		—		—		6,000		—		6,000
Commercial paper	—		—		—		—		—		45,063		—		45,063
Corporate debt securities	—		—		—		—		—		3,819		—		3,819
Money market funds	195,805		—		—		195,805		98,467		—		—		98,467
U.S. Treasury securities	—		—		—		—		—		30,988		—		30,988
Short term investments
Certificates of deposit	—		5,000		—		5,000		—		52,428		—		52,428
Commercial paper	—		2,999		—		2,999		—		64,354		—		64,354
Corporate debt securities	—		185,994		—		185,994		—		367,765		—		367,765
U.S. Treasury securities	—		49,871		—		49,871		—		598,368		—		598,368
Other current assets
Foreign currency forward contracts	—		230		—		230		—		235		—		235
Total assets	$	195,805	$	244,094	$	—	$	439,899	$	98,467	$	1,182,966	$	—	$	1,281,433

Liabilities
Accrued expenses
Foreign currency forward contracts	$	—	$	496	$	—	$	496	$	—	$	1,845	$	—	$	1,845
Contingent consideration	—		—		9,052		9,052		—		—		8,000		8,000
Other liabilities
Contingent consideration	—		—		—		—		—		—		8,000		8,000
Total Liabilities	$	—	$	496	$	9,052	$	9,548	$	—	$	1,845	$	16,000	$	17,845

During the nine months ended March 30, 2019 and the year ended June 30, 2018 , there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

There were no assets or liabilities measured at fair value on a non-recurring basis as of March 30, 2019 and June 30, 2018 other than impairments of long-lived assets. The Company uses various inputs to evaluate investments in privately held companies, including valuations of recent financing events as well as other relevant information regarding the performance of the issuer. There were no material impairments of long-lived assets in any of the periods presented.

NOTE 5: FINANCIAL INSTRUMENTS

Short-term investments

Fair values were as follows:



	March 30, 2019									June 30, 2018
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
	(in thousands)
Available-for-sale investments
Certificates of deposit	$	5,000	$	—	$	—		$	5,000	$	52,429	$	—	$	(1	)	$	52,428
Commercial paper	2,999		—		—			2,999		64,354		—		—			64,354
Corporate debt securities	186,446		21		(473		)	185,994		369,734		39		(2,008		)	367,765
U.S. Treasury securities	49,973		—		(102		)	49,871		600,068		10		(1,710		)	598,368
Total available-for-sale investments	$	244,418	$	21	$	(575	)	$	243,864	$	1,086,585	$	49	$	(3,719	)	$	1,082,915

In the three and nine months ended March 30, 2019 and June 30, 2018 , the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between April 1, 2019 and March 12, 2021.

The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes.

Derivative instruments and hedging activities

The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S.

The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.

Derivatives designated as cash flow hedging instruments

The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of March 30, 2019 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $44.4 million and $49.7 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0 and $1.2 million , respectively.

Derivatives not designated as hedging instruments

As of March 30, 2019 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $19.9 million and $21.1 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $21.9 million and $21.3 million , respectively. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and nine months ended March 30, 2019 and March 31, 2018 .

Effect of hedge accounting on the Condensed Consolidated Statements of Income

The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income:



	Three Months Ended							Nine Months Ended
	March 30, 2019							March 30, 2019
	Net Revenue		Cost of Goods Sold		Operating Expenses				Net Revenue		Cost of Goods Sold			Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	542,383	$	201,552	$	183,691			$	1,757,784	$	613,669		$	570,588

Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	6	$	261	$	(79	)		$	50	$	(335	)	$	(1,906	)



	Three Months Ended							Nine Months Ended
	March 31, 2018							March 31, 2018
	Net Revenue			Cost of Goods Sold		Operating Expenses			Net Revenue			Cost of Goods Sold		Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	648,599		$	224,653	$	199,108		$	1,846,913		$	639,460	$	596,401

Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	(11	)	$	165	$	356		$	(64	)	$	116	$	1,781

Outstanding debt obligations

The following table summarizes the Company’s outstanding debt obligations:



	March 30, 2019			June 30, 2018
	(in thousands)
3.45% fixed rate notes due June 2027	$	500,000		$	500,000
2.5% fixed rate notes due November 2018	—			500,000
3.375% fixed rate notes due March 2023	500,000			500,000
Total outstanding debt	1,000,000			1,500,000
Less: Current portion (included in "Current portion of debt")	—			(499,406		)
Less: Reduction for unamortized discount and debt issuance costs	(7,775		)	(9,447		)
Total long-term debt	$	992,225		$	991,147

On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5% . Interest on

the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million , after issuing at a discount and deducting paid expenses.

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million , after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5% . Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million , after issuing at a discount and deducting paid expenses.

The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest.

The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $12.4 million during the three months ended March 30, 2019 and March 31, 2018 , respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $32.5 million and $37.1 million during the nine months ended March 30, 2019 and March 31, 2018 , respectively.

The estimated fair value of the Company’s outstanding debt obligations was approximately $985 million as of March 30, 2019 . The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.

The Company recorded interest expense of $9.3 million and $12.4 million during the three months ended March 30, 2019 , and March 31, 2018 , respectively. The Company recorded interest expense of $33.9 million and $37.6 million during the nine months ended March 30, 2019 and March 31, 2018 , respectively.

Other Financial Instruments

For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

NOTE 6: STOCK-BASED COMPENSATION

At March 30, 2019 , the Company had one stock incentive plan, the Company's 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESPP”). The 1996 Plan was adopted by the Board of Directors to provide the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), and market stock units (“MSUs”) to employees, directors, and consultants.

Pursuant to the 1996 Plan, the exercise price for incentive stock options and non-statutory stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Options generally expire no later than seven years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service.

RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. RSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

MSUs granted to employees typically vest over a four-year cliff period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are

released at the end of the performance period can range from zero to a maximum cap depending on the Company's performance. MSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 30, 2019 and March 31, 2018 , respectively:



	Three Months Ended
	March 30, 2019								March 31, 2018
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	8	$	1,951	$	654	$	2,613	$	35	$	2,003	$	537	$	2,575
Research and development	5		9,399		1,658		11,062		13		8,725		1,339		10,077
Selling, general and administrative	64		8,184		897		9,145		51		7,218		684		7,953
Pre-tax stock-based compensation expense	$	77	$	19,534	$	3,209	$	22,820	$	99	$	17,946	$	2,560	$	20,605
Less: income tax effect							1,946								2,053
Net stock-based compensation expense							$	20,874							$	18,552



	Nine Months Ended
	March 30, 2019								March 31, 2018
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	28	$	5,597	$	1,656	$	7,281	$	196	$	5,783	$	1,482	$	7,461
Research and development	27		26,783		3,948		30,758		507		24,212		3,342		28,061
Selling, general and administrative	178		24,600		2,156		26,934		636		21,004		1,770		23,410
Pre-tax stock-based compensation expense	$	233	$	56,980	$	7,760	$	64,973	$	1,339	$	50,999	$	6,594	$	58,932
Less: income tax effect							6,214								6,830
Net stock-based compensation expense							$	58,759							$	52,102

The expenses included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $3.0 million and $2.2 million for the three months ended March 30, 2019 and March 31, 2018 , respectively, and $8.3 million and $5.8 million for the nine months ended March 30, 2019 and March 31, 2018 , respectively.

Stock Options

The fair value of options granted to employees under the 1996 Plan is estimated on the date of grant using the Black-Scholes option valuation model.

There were no stock options granted in the three and nine months ended March 30, 2019 and March 31, 2018 .

The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 30, 2019 and related activity for the nine months ended March 30, 2019 :



	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value ⁽¹⁾
Balance at June 30, 2018	1,688,253		$	27.72
Options Granted	—		—
Options Exercised	(699,416	)	27.13
Options Cancelled	(3,439	)	28.08
Balance at March 30, 2019	985,398		$	28.14	1.3	$	25,692,173
Exercisable, March 30, 2019	985,398		$	28.14	1.3	$	25,692,173
Vested and expected to vest, March 30, 2019	985,398		$	28.14	1.3	$	25,692,173



(1)	Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 30, 2019.

As of March 30, 2019 , there was no unrecognized stock compensation from unvested stock options.

Restricted Stock Units and Other Awards

The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.

The weighted-average fair value of RSUs and other awards granted was $51.01 and $54.81 per share for the three months ended March 30, 2019 and March 31, 2018 , respectively, and $54.04 and $44.49 per share for the nine months ended March 30, 2019 and March 31, 2018 , respectively.

The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 30, 2019 and related activity during the nine months ended March 30, 2019 :



	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value ⁽¹⁾
Balance at June 30, 2018	5,524,432
Restricted stock units and other awards granted	1,614,379
Restricted stock units and other awards released	(1,377,399	)
Restricted stock units and other awards cancelled	(458,762	)
Balance at March 30, 2019	5,302,650		2.7	$	287,456,657
Outstanding and expected to vest, March 30, 2019	4,439,502		2.7	$	240,665,404



(1)	Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 30, 2019.

The Company withheld shares totaling $23.0 million in value as a result of employee withholding taxes based on the value of RSUs on vesting date for the nine months ended March 30, 2019 . Total payments for employees’ tax obligations to taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows.

As of March 30, 2019 , there was $162.6 million of unrecognized compensation expense related to 5.3 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.7 years .

Market Stock Units (MSUs)

The Company grants MSUs to senior members of management in lieu of granting stock options. For MSUs granted prior to September 2017, the performance metrics of this program are based on relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index SPDR S&P (the “XSD”). For MSUs granted in September 2017 and after, the performance metrics for this program are based on the total shareholder return ("TSR") of the Company relative to the TSR of the other companies included in the XSD. The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD or the TSR of the companies included in the XSD, as applicable. Vesting for MSUs is contingent upon both service and market conditions and has a four-year vesting cliff period. MSUs granted after August 2017 vest based upon annual performance and are subject to continued service through the end of the four-year period, but will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

The weighted-average fair value of MSUs granted was $75.48 and $51.03 per share for the nine months ended March 30, 2019 and March 31, 2018 , respectively.

The following table summarizes the number of MSUs outstanding and expected to vest as of March 30, 2019 and their activity during the nine months ended March 30, 2019 :



	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value ⁽¹⁾
Balance at June 30, 2018	1,079,064
Market stock units granted	247,804
Market stock units released	(13,594	)
Market stock units cancelled	(264,742	)
Balance at March 30, 2019	1,048,532		2.7	$	56,840,920
Outstanding and expected to vest, March 30, 2019	976,524		2.7	$	52,937,345



(1)	Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 30, 2019.

As of March 30, 2019 , there was $31.3 million of unrecognized compensation expense related to 1.0 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 2.7 years .

Employee Stock Purchase Plan

Employees are granted rights to acquire common stock under the 2008 ESPP.

The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding:



	Three Months Ended		Nine Months Ended
	March 30, 2019	March 31, 2018	March 30, 2019	March 31, 2018
Expected holding period (in years)	0.5 years	0.5 years	0.5 years	0.5 years
Risk-free interest rate	2.4% - 2.6%	1.1% - 1.5%	1.6% - 2.6%	0.8% - 1.5%
Expected stock price volatility	27.5 % - 28.9%	20.5% - 20.7%	19.6% - 32.7 %	19.1% - 24.7%
Dividend yield	2.8% - 3.1%	3.0% - 3.1%	2.8% - 3.1%	3.0% - 3.4%

As of March 30, 2019 , there was $5.3 million of unrecognized compensation expense related to the 2008 ESPP.

NOTE 7: EARNINGS PER SHARE

Basic earnings per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock

excludes unvested RSUs and other awards as well as MSUs. Diluted earnings per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and other awards as well as MSUs, and assumed issuance of common stock under the 2008 ESPP using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share:



	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands, except per share data)
Numerator for basic earnings per share and diluted earnings per share
Net income	$	130,613	$	193,627	$	459,928	$	273,146

Denominator for basic earnings per share	273,221		280,850		275,831		281,525
Effect of dilutive securities:
Stock options, ESPP, RSUs, and MSUs	3,389		5,031		3,849		4,696
Denominator for diluted earnings per share	276,610		285,881		279,680		286,221

Earnings per share
Basic	$	0.48	$	0.69	$	1.67	$	0.97
Diluted	$	0.47	$	0.68	$	1.64	$	0.95

For the three months ended March 30, 2019 and March 31, 2018 , and the nine months ended March 30, 2019 and March 31, 2018 , no stock awards were determined to be anti-dilutive. Therefore, none were excluded from the calculation of diluted earnings per share.

NOTE 8: SEGMENT INFORMATION

The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. All of the Company's products are designed through a centralized R&D function, manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors.

The Company currently has one operating segment and reportable segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280” ) , the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment.

Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year.

Net revenues from unaffiliated customers by geographic region were as follows:



	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
United States	$	63,970	$	75,760	$	200,944	$	223,021
China	183,753		219,160		611,768		662,114
Rest of Asia	176,396		222,207		583,616		586,109
Europe	104,124		114,254		316,155		329,939
Rest of World	14,140		17,218		45,301		45,730
	$	542,383	$	648,599	$	1,757,784	$	1,846,913

Net long-lived assets by geographic region were as follows:



	March 30, 2019		June 30, 2018
	(in thousands)
United States	$	359,743	$	361,432
Philippines	110,214		120,657
Rest of World	101,998		97,275
	$	571,955	$	579,364

NOTE 9: COMPREHENSIVE INCOME (LOSS)

The changes in accumulated other comprehensive income (loss) by component and related tax effects in the nine months ended March 30, 2019 and March 31, 2018 were as follows:



(in thousands)	Unrealized Gains and (Losses) on Intercompany Receivables			Unrealized Gains and (Losses) on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and (Losses) on Cash Flow Hedges			Unrealized Gains and (Losses) on Available-For-Sale Securities			Total
June 30, 2018	$	(6,280	)	$	(2,516	)	$	(1,136	)	$	(1,383	)	$	(3,670	)	$	(14,985	)
Other comprehensive income (loss) before reclassifications	—			—			—			(783		)	3,247			2,464
Amounts reclassified out of accumulated other comprehensive loss (income)	—			292			—			2,191			—			2,483
Tax effects	—			(60		)				(241		)	(131		)	(432		)
Other comprehensive income, net	—			232			—			1,167			3,116			4,515
March 30, 2019	$	(6,280	)	$	(2,284	)	$	(1,136	)	$	(216	)	$	(554	)	$	(10,470	)



(in thousands)	Unrealized Gains and (Losses) on Intercompany Receivables			Unrealized Gains and (Losses) on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and (Losses) on Cash Flow Hedges			Unrealized Gains and (Losses) on Available-For-Sale Securities			Total
June 24, 2017	$	(6,280	)	$	(1,258	)	$	(1,136	)	$	18		$	(1,234	)	$	(9,890	)
Other comprehensive income (loss) before reclassifications	—			—			—			2,012			(3,707		)	(1,695		)
Amounts reclassified out of accumulated other comprehensive loss (income)	—			154			—			(1,834		)	—			(1,680		)
Tax effects	—			(168		)	—			(45		)	274			61
Other comprehensive income (loss), net	—			(14		)	—			133			(3,433		)	(3,314		)
March 31, 2018	$	(6,280	)	$	(1,272	)	$	(1,136	)	$	151		$	(4,667	)	$	(13,204	)

NOTE 10: INCOME TAXES

In the three and nine months ended March 30, 2019 , the Company recorded an income tax provision of $29.8 million and $116.8 million , respectively, compared to $28.7 million and $328.0 million for the three and nine months ended March 31, 2018 , respectively. The Company’s effective tax rate for the three and nine months ended March 30, 2019 was 18.6% and 20.3% , respectively, compared to the 12.9% and 54.6% for the three and nine months ended March 31, 2018 , respectively.

On December 22, 2017 legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of our foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period, the Company gathered information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019 the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the nine months ended March 30, 2019 by 3.8% . As of the end of the second quarter of fiscal year 2019, the accounting for income tax effects of the Act has been completed.

The Act reduced the federal statutory tax rate from 35% to 21% , effective January 1, 2018, which resulted in a fiscal year 2018 federal statutory tax rate of 28.1% for the Company (average of a 35% rate for the first half of fiscal year 2018 and a 21% rate for the second half of fiscal year 2018). The Company’s federal statutory tax rate for fiscal year 2019 is 21% . In the second quarter of fiscal year 2018, the Company recorded a $13.7 million discrete charge to remeasure deferred tax assets and liabilities as of the enactment date of the Act to reflect the federal statutory tax rate reductions.

The Act included Global Intangible Low-Taxed Income (“GILTI”) provisions, which first impact the Company in fiscal year 2019. The GILTI provisions effectively subject income earned by the Company’s foreign subsidiaries to current U.S. tax at a rate of 10.5%, less foreign tax credits. The Company has elected to treat tax generated by the GILTI provisions as a period expense.

The Company’s federal statutory tax rate for fiscal year 2019 is 21% . The Company’s effective tax rate for the three months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by tax generated by the GILTI provisions, a $4.1 million discrete charge for differences between the Company's fiscal year 2018 tax returns and the tax provision originally recorded, and $5.7 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by $21.0 million of discrete charges for the Transition Tax, tax generated by the GILTI provisions, $15.1 million of discrete interest accruals for unrecognized tax benefits, and $4.8 million of discrete charges for differences between the Company's fiscal year 2018 tax returns and the tax provision originally recorded.

The Company’s federal statutory tax rate for fiscal year 2018 was 28.1% . The Company’s effective tax rate for the three months ended March 31, 2018 , was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, and $4.6 million of discrete excess tax benefits generated by the settlement of share-based awards, partially offset by $5.1 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 31, 2018 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Transition Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, and $13.1 million of discrete interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates and $8.3 million of discrete excess tax benefits generated by the settlement of share-based awards.

The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that gross unrecognized tax benefits, including accrued interest and penalties, could decrease up to $448 million within the next twelve months, primarily due to the completion of federal tax audits, including any administrative appeals. The $448 million primarily relates to matters involving federal taxation of cross-border transactions.

The Company’s federal corporate income tax returns are audited on a recurring basis by the Internal Revenue Service (“IRS”). The IRS concluded its field examination of the Company’s federal corporate income tax returns for fiscal years 2009 through 2011 and issued an IRS Revenue Agent's Report in July 2016 that included proposed adjustments for transfer pricing issues related to cost sharing and buy-in license payments for the use of intangible property by one of the Company’s international subsidiaries. The Company disagreed with the proposed transfer pricing adjustments and related penalties, and in September 2016, the Company filed a protest to challenge the proposed adjustments and request a conference with the Appeals Office of the IRS. In May 2018, a preliminary understanding was reached with the IRS regarding the contested issues for the audit and post-audit years, which the Company expects may be finalized in fiscal year 2019 with the execution of a closing agreement. In June 2018, the Company made advance payments for audit and post-audit years tax of $140.7 million and interest of $37.4 million . These payments will reduce the accrual of interest on audit and post-audit years tax deficiencies that would be owed if the preliminary understanding is finalized. The Company’s reserves for unrecognized tax benefits are sufficient to cover the audit and post-audit years tax deficiencies that would be owed as a result of the preliminary understanding. In fiscal year 2017, the IRS commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2012 through 2014, which is ongoing. In the first quarter of fiscal year 2019, the Company was notified that the IRS will commence an audit of the Company's federal corporate income tax returns for fiscal years 2015 through 2016.

NOTE 11: COMMITMENTS AND CONTINGENCIES

Legal Proceedings

The Company is party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual property matters. While the outcome of these matters cannot be predicted with certainty, the Company does not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any.

Indemnification

The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims.

Pursuant to the Company's charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.

NOTE 12: COMMON STOCK REPURCHASES

On July 20, 2017, the Board of Directors of the Company authorized the repurchase of up to $1 billion of the Company's common stock. The stock repurchase authorization did not have an expiration date and the pace of repurchase activity depended on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase

authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization.

On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $ 1.5 billion of the Company’s common stock. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization.

During the nine months ended March 30, 2019 , the Company repurchased approximately 8.0 million shares of its common stock for $437.0 million . As of March 30, 2019 , the Company had remaining authorization of $1.2 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

NOTE 13: ACQUISITION

On January 26, 2018, the Company acquired a privately-held corporation specializing in the development of high-performance USB and video extension technology. Total cash consideration paid in connection with this acquisition was $57.8 million , net of cash acquired. The Company also agreed to pay up to an additional $16.0 million if the acquired business achieves certain financial milestones for the annual period ended August 31, 2018 and annual period ending August 31, 2019. Out of the $16.0 million , $8.0 million was paid during the nine months ended March 30, 2019 . The acquired assets included $26.0 million of developed technology and $10.5 million of other intangible assets. The Company also recorded $41.9 million of goodwill in connection with this acquisition. The goodwill is not deductible for tax purposes.

NOTE 14: GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable.

There were no changes to goodwill for the nine months ended March 30, 2019 .

No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018 , respectively.

Intangible assets consisted of the following:



	March 30, 2019						June 30, 2018
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	488,846	$	443,020	$	45,826	$	485,465	$	423,869	$	61,596
Customer relationships	116,505		105,229		11,276		116,294		103,217		13,077
Trade name	9,974		8,830		1,144		9,340		8,588		752
Patents	2,500		2,500		—		2,500		2,469		31
Total amortizable purchased intangible assets	617,825		559,579		58,246		613,599		538,143		75,456
In-process research & development (IPR&D)	2,790		—		2,790		2,790		—		2,790
Total purchased intangible assets	$	620,615	$	559,579	$	61,036	$	616,389	$	538,143	$	78,246

The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:



	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
Cost of goods sold	$	5,368	$	12,101	$	19,151	$	34,305
Intangible asset amortization	756		876		2,285		3,623
Total intangible asset amortization expenses	$	6,124	$	12,977	$	21,436	$	37,928

The following table represents the estimated future amortization expense of intangible assets as of March 30, 2019 :



Fiscal Year	Amount
	(in thousands)
Remaining three months of 2019	$	4,793
2020	15,068
2021	13,368
2022	7,689
2023	7,205
Thereafter	10,123
Total intangible assets	$	58,246

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Maxim Integrated Products, Inc. (“Maxim Integrated” or the “Company” and also referred to as “we,” “our” or “us”) disclaims any duty to and undertakes no obligation to update any forward-looking statement, whether as a result of new information relating to existing conditions, future events or otherwise or to release publicly the results of any future revisions it may make to forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by federal securities laws. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date of this Quarterly Report on Form 10-Q. Readers should carefully review future reports and documents that the Company files with or furnishes to the SEC from time to time, such as its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, and any Current Reports on Form 8-K.

Overview of Business

Maxim Integrated is incorporated in the state of Delaware. Maxim Integrated designs, develops, manufactures and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of geographically diverse customers. We also provide a range of high-frequency process technologies and capabilities that can be used in custom designs. The analog market is fragmented and characterized by many diverse applications, a great number of product variations and, with respect to many circuit types, relatively long product life cycles. We are a global company with a wafer manufacturing facility in the U.S., testing facilities in the Philippines and Thailand, and sales and circuit design offices around the world. We also utilize third party foundries for manufacturing of our products. The major end-markets in which our products are sold are the Automotive, Communications and Data Center, Computing, Consumer and Industrial markets.

CRITICAL ACCOUNTING POLICIES

The methods, estimates, and judgments we use in applying our most critical accounting policies have a significant impact on the results we report in our financial statements. The Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as the ones that are most important to the presentation of our financial condition and results of operations, and that require us to make our most difficult and subjective accounting judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, our most critical accounting policies include revenue recognition, which impacts the recording of net revenues; valuation of inventories, which impacts costs of goods sold and gross margins; the assessment of recoverability of long-lived assets, which impacts impairment of long-lived assets; assessment of recoverability of intangible assets and goodwill, which impacts impairment of goodwill and intangible assets; accounting for income taxes, which impacts the income tax provision; and assessment of litigation and contingencies, which impacts charges recorded in cost of goods sold, selling, general and administrative expenses and income taxes. These policies and the estimates and judgments involved are discussed further in the Management’s Discussion and Analysis of Financial Condition in our Annual Report on Form 10-K for the fiscal year ended June 30, 2018 . We have other significant accounting policies that either do not generally require estimates and judgments that are as difficult or subjective, or it is less likely that such accounting policies would have a material impact on our reported results of operations for a given period.

Except for the accounting policies and estimates outlined under Part I, Item 1. Financial Statements - Note 2, there have been no material changes during the nine months ended March 30, 2019 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2018 .

RESULTS OF OPERATIONS

The following table sets forth certain Condensed Consolidated Statements of Income data expressed as a percentage of net revenues for the periods indicated:



	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018

Net revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of goods sold	37.2	%	34.6	%	34.9	%	34.6	%
Gross margin	62.8	%	65.4	%	65.1	%	65.4	%
Operating expenses:
Research and development	19.7	%	17.6	%	18.8	%	18.3	%
Selling, general and administrative	13.7	%	12.5	%	13.3	%	13.0	%
Intangible asset amortization	0.1	%	0.1	%	0.1	%	0.2	%
Impairment of long-lived assets	—	%	—	%	—	%	—	%
Severance and restructuring expenses	0.3	%	0.4	%	0.2	%	0.8	%
Other operating expenses (income), net	—	%	—	%	—	%	(0.1	)%
Total operating expenses	33.8	%	30.6	%	32.4	%	32.2	%
Operating income	29.0	%	34.7	%	32.6	%	33.2	%
Interest and other income (expense), net	0.6	%	(0.4	)%	0.2	%	(0.5	)%
Income before provision for income taxes	29.6	%	34.3	%	32.8	%	32.7	%
Income tax provision (benefit)	5.5	%	4.4	%	6.6	%	17.8	%
Net income	24.1	%	29.9	%	26.2	%	14.9	%

The following table shows stock-based compensation included in the components of the Condensed Consolidated Statements of Income reported above as a percentage of net revenues for the periods indicated:



	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Cost of goods sold	0.5	%	0.4	%	0.4	%	0.4	%
Research and development	2.0	%	1.6	%	1.7	%	1.5	%
Selling, general and administrative	1.7	%	1.2	%	1.5	%	1.3	%
	4.2	%	3.2	%	3.6	%	3.2	%

Net Revenues

Net revenues were $542.4 million and $648.6 million for the three months ended March 30, 2019 and March 31, 2018 , respectively. Revenue from consumer products was down by 27%, mainly due to lower shipments in cell phone and home entertainment products, partially offset by higher shipments in wearable products. Revenue from industrial products was down by 18%, mainly due to a decline in shipments of control, automation and automatic test equipment products. Revenue from communications and data center products was down by 22%, due to generally lower shipments of server, network and data center products. These declines were partially offset by an increase in revenue from automotive products. Revenue from automotive products was up by 5%, driven by higher demand for battery management systems and driver assistance content.

Net revenues were $1.8 billion for both the nine months ended March 30, 2019 and March 31, 2018 . Revenue from automotive products was up by 7%, driven by higher demand for battery management systems and driver assistance content. Revenue from communications and data center products was down by 12% due to generally lower shipments of network, server, and data center products. Revenue from industrial products was down by 7%, driven by lower demand for control, automation, security and other industrial products, partially offset by higher demand for USB extension products. Revenue from consumer products was down by 6%, driven by lower demand for cell phone and home entertainment products, partially offset by higher demand for wearable

and handheld computing products. The decrease in revenues in these markets was partially driven by the 13-week second quarter of fiscal year 2019, compared to the 14-week second quarter of fiscal year 2018. In addition, there was a one-time incremental $22.0 million of revenue recognized as a result of the sell-in accounting revenue transition during the second quarter of fiscal 2018.

During both the three months ended March 30, 2019 and March 31, 2018 , approximately 88% of net revenues, were derived from customers outside of the United States. While less than 1.0% of our sales are denominated in currencies other than U.S. dollars, we enter into foreign currency forward contracts to mitigate our risks on firm commitments and net monetary assets denominated in foreign currencies. The impact of changes in foreign exchange rates on our revenue and results of operations for the three months ended March 30, 2019 and March 31, 2018 was immaterial.

Gross Margin

Our gross margin percentages were 62.8% and 65.4% for the three months ended March 30, 2019 and March 31, 2018 , respectively. Our gross margin decreased by 2.6 percentage points, primarily due to higher inventory reserves.

Our gross margin percentages were 65.1% and 65.4% for the nine months ended March 30, 2019 and March 31, 2018 , respectively. Our gross margin decreased by 0.3 percentage points, primarily due to higher inventory reserves.

Research and Development

Research and development expenses were $107.1 million and $114.4 million for the three months ended March 30, 2019 and March 31, 2018 , respectively, which represented 19.7% and 17.6% of net revenues for each respective period. The $7.3 million decrease was due to lower salaries and related personnel expenses.

Research and development expenses were $330.1 million and $338.9 million for the nine months ended March 30, 2019 and March 31, 2018 , respectively, which represented 18.8% and 18.3% of net revenues for each respective period. The $8.8 million decrease was due to lower salaries and related personnel expenses.

Selling, General and Administrative

Selling, general and administrative expenses were $74.1 million and $81.3 million for the three months ended March 30, 2019 and March 31, 2018 , respectively, which represented 13.7% and 12.5% of net revenues for each respective period. The $7.2 million decrease was due to lower salaries and related personnel expenses.

Selling, general and administrative expenses were $233.5 million and $240.3 million for the nine months ended March 30, 2019 and March 31, 2018 , respectively, which represented 13.3% and 13.0% of net revenues for each respective period. The $6.8 million decrease was due to lower salaries and related personnel expenses.

Severance and Restructuring Expenses

Severance and restructuring expenses were $1.7 million and $2.3 million for the three months ended March 30, 2019 and March 31, 2018 , respectively, which represented 0.3% and 0.4% of net revenues for each respective period. The $0.5 million decrease was primarily due to a decrease in restructuring activities.

Severance and restructuring expenses were $3.9 million and $14.2 million for the nine months ended March 30, 2019 and March 31, 2018 , respectively, which represented 0.2% and 0.8% of net revenues for each respective period. The $10.3 million decrease was primarily due to a decrease in restructuring activities.

Provision for Income Taxes

In the three and nine months ended March 30, 2019, the Company recorded an income tax provision of $29.8 million and $116.8 million, respectively, compared to $28.7 million and $328.0 million for the three and nine months ended March 31, 2018, respectively. The Company’s effective tax rate for the three and nine months ended March 30, 2019 was 18.6% and 20.3%, respectively, compared to 12.9% and 54.6% for the three and nine months ended March 31, 2018, respectively.

No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period the Company gathered information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019 the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the nine months ended March 30, 2019 by 3.8%. As of the end of the second quarter of fiscal year 2019 accounting for the income tax effects of the Act were completed.

The Act reduced the federal statutory tax rate from 35% to 21%, effective January 1, 2018, which resulted in a fiscal year 2018 federal statutory tax rate of 28.1% for the Company (average of a 35% rate for the first half of fiscal year 2018 and a 21% rate for the second half of fiscal year 2018). The Company’s federal statutory tax rate for fiscal year 2019 is 21%. In the second quarter of fiscal year 2018 the Company recorded a $13.7 million discrete charge to remeasure deferred tax assets and liabilities as of the enactment date of the Act to reflect the federal statutory tax rate reductions.

The Company’s federal statutory tax rate for fiscal year 2019 is 21%. The Company’s effective tax rate for the three months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by tax generated by the GILTI provisions, a $4.1 million discrete charge for differences between our fiscal year 2018 tax returns and the tax provision originally recorded, and $5.7 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by $21.0 million of discrete charges for the Transition Tax , tax generated by GILTI provisions, $15.1 million of discrete interest accruals for unrecognized tax benefits, and $4.8 million of discrete charges for differences between our fiscal year 2018 tax returns and the tax provision originally recorded.

The Company’s federal statutory tax rate for fiscal year 2018 was 28.1%. The Company’s effective tax rate for the three months ended March 31, 2018 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, and $4.6 million of discrete excess tax benefits generated by the settlement of share-based awards, partially offset by $5.1 million of discrete interest accruals for unrecognized tax benefits.

BACKLOG

As of March 30, 2019 and June 30, 2018 , our current quarter backlog was approximately $398.8 million and $441.1 million , respectively. In backlog, we include orders with customer request dates within the next three months. As is customary in the semiconductor industry, these orders may be canceled in most cases without penalty to customers. Accordingly, we believe that our backlog is not a reliable measure of future revenues. All backlog numbers have been adjusted for estimated future distribution ship and debit pricing adjustments.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Financial Condition

Cash flows were as follows:



	Nine Months Ended
	March 30, 2019			March 31, 2018
	(in thousands)
Net cash provided by (used in) operating activities	$	638,373		$	672,805
Net cash provided by (used in) investing activities	785,387			(708,819		)
Net cash provided by (used in) financing activities	(1,312,681		)	(580,514		)
Net increase (decrease) in cash and cash equivalents	$	111,079		$	(616,528	)

Operating activities

Cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities.

Cash provided by operating activities was $638.4 million in the nine months ended March 30, 2019 , a decrease of $34.4 million compared with the nine months ended March 31, 2018 . This decrease was due to changes in working capital and adjustments for non-cash items, partially offset by higher net income.

Investing activities

Investing cash flows consist primarily of net investment purchases and maturities, and capital expenditures.

Cash provided by investing activities was $785.4 million for the nine months ended March 30, 2019 , compared with cash used in investing activities of $708.8 million for the nine months ended March 31, 2018 , a change of $1.5 billion . The change was due to lower purchases of and higher proceeds from maturity of available-for-sale securities.

Financing activities

Financing cash flows consist primarily of debt issuance, repurchases of common stock, and payment of dividends to stockholders.

Net cash used in financing activities increased by approximately $732.2 million for the nine months ended March 30, 2019 compared to the nine months ended March 31, 2018 . The increase was due to the repayment of the November 2018 Notes and repurchases of our common stock.

Liquidity and Capital Resources

As of March 30, 2019 , our available funds consisted of $1.9 billion in cash, cash equivalents and short-term investments. We anticipate that the available funds and cash generated from operations will be sufficient to meet cash and working capital requirements, including the anticipated level of capital expenditures, common stock repurchases, debt repayments and dividend payments for at least the next twelve months.

In November 2018, the Company repaid $500.0 million of principal and related outstanding interest of the Company's 2.5% coupon notes.

In January 2019, the Company terminated its $350.0 million revolving credit facility with certain institutional lenders.

On October 30, 2018, we were authorized to repurchase up to $1.5 billion of the Company's common stock. During the three and nine months ended March 30, 2019 , we repurchased an aggregate of $ 117.0 million and $437.0 million , respectively, of the Company's common stock.

During the three and nine months ended March 30, 2019 , we paid cash dividends of $0.46 and $1.38 per common share totaling $125.6 million and $380.2 million , respectively.

Off-Balance-Sheet Arrangements

As of March 30, 2019 , we did not have any material off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company’s market risk has not changed materially from the interest rate and foreign currency risks disclosed in Item 7A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2018 .

The impact of inflation and changing prices on the Company’s net revenues and on operating income during the three and nine months ended March 30, 2019 and March 31, 2018 was not material.

ITEM 4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer (“CEO”) and our chief financial officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of March 30, 2019 . Our management, including the CEO and the CFO, has concluded that the Company’s disclosure controls and procedures were effective as of March 30, 2019 . The purpose of these controls and procedures is to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules, and that such information is accumulated and communicated to our management, including our CEO and our CFO, to allow timely decisions regarding required disclosures.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 30, 2019 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Inherent Limitations on the Effectiveness of Internal Controls

A system of internal control over financial reporting is intended to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements in accordance with GAAP, and no control system, no matter how well designed and operated, can provide absolute assurance. The design of any control system is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of its inherent limitations, internal control over financial reporting may not prevent or detect financial statement errors and misstatements. Also, projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

PART II. OTHER INFORMATION

ITEM 1: LEGAL PROCEEDINGS

The information set forth above under Part I, Item 1, Note 11 “Commitments and Contingencies” to the Condensed Consolidated Financial Statements is incorporated herein by reference.

ITEM 1A: RISK FACTORS

A description of risks associated with our business, financial condition and results of our operations is set forth in Item 1A - Risk Factors of our Annual Report on Form 10-K for the fiscal year ended June 30, 2018 , which is incorporated herein by reference.

ITEM 2: UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On July 20, 2017, the Board of Directors of the Company authorized the repurchase of up to $1.0 billion of the Company's common stock. The stock repurchase authorization did not have an expiration date and the pace of repurchase activity depended on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. The Company's prior repurchase authorization was cancelled and superseded by this repurchase authorization.

On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $1.5 billion of the Company’s common stock. This stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. The Company’s prior repurchase authorization was cancelled and superseded by this new repurchase authorization.

The following table summarizes the activity related to stock repurchases for the three months ended March 30, 2019 :



	Issuer Repurchases of Equity Securities
	(in thousands, except per share amounts)
	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
Dec 30, 2018 - Jan 26, 2019	1,076	$	51.03	1,076	$	1,279,163
Jan 27, 2019 - Feb 23, 2019	769	55.05		769	1,236,842
Feb 24, 2019 - Mar 30, 2019	365	54.18		365	1,217,087
Total for the quarter	2,210	$	52.95	2,210	$	1,217,087

In the fiscal quarter ended March 30, 2019 , the Company repurchased approximately 2.2 million shares of its common stock for approximately $117.0 million . As of March 30, 2019 , the Company had remaining authorization of $1.2 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

ITEM 3: DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4: MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5: OTHER INFORMATION

None.

ITEM 6: EXHIBITS

(a) Exhibits



31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act (1)
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act (1)
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 (1)
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 (1)
EX-101.INS	XBRL INSTANCE DOCUMENT (1)
EX-101.SCH	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT (1)
EX-101.CAL	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT (1)
EX-101.DEF	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT (1)
EX-101.LAB	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT (1)
EX-101.PRE	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT (1)



(1) Filed or furnished herewith.

In accordance with Rule 406T of Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



May 1, 2019		MAXIM INTEGRATED PRODUCTS, INC.

		By:/s/ Bruce E. Kiddoo

		Bruce E. Kiddoo
		Senior Vice President, Chief Financial Officer and Chief Accounting Officer

TABLE OF CONTENTS

Part I. Financial Informationprint Item 1. Financial Statements (unaudited)print Note 1: Basis Of Presentationprint Note 2: Summary Of Significant Accounting Policiesprint Note 3: Balance Sheet Componentsprint Note 4: Fair Value Measurementsprint Note 5: Financial Instrumentsprint Note 6: Stock-based Compensationprint Note 7: Earnings Per Shareprint Note 8: Segment Informationprint Note 9: Comprehensive Income (loss)print Note 10: Income Taxesprint Note 11: Commitments and Contingenciesprint Note 12: Common Stock Repurchasesprint Note 13: Acquisitionprint Note 14: Goodwill and Intangible Assetsprint Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operationsprint Item 3: Quantitative and Qualitative Disclosures About Market Riskprint Item 4: Controls and Proceduresprint Part II. Other Informationprint Item 1: Legal Proceedingsprint Item 1A: Risk Factorsprint Item 2: Unregistered Sales Of Equity Securities and Use Of Proceedsprint Item 3: Defaults Upon Senior Securitiesprint Item 4: Mine Safety Disclosuresprint Item 5: Other Informationprint Item 6: Exhibitsprint

Exhibits

31.1 Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act(1) 31.2 Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act(1) 32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 (1) 32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 (1)

Supplier name	Ticker
3M Company	MMM
International Business Machines Corporation	IBM
Applied Materials, Inc.	AMAT
Newmont Corporation	NEM
Intel Corporation	INTC
Lam Research Corporation	LRCX
Southern Copper Corporation	SCCO
Taiwan Semiconductor Manufacturing Company Limited	TSM

MXIM 10-Q Quarter ended March 30, 2019

Exhibits